Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aung Pyae Phyo

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Antimicrobial Agents and Chemotherapy|January 19, 2012
Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malariaJoel Tarning, Marcus J Rijken, Rose McGready, et al.
Malaria Journal|November 28, 2017
Plasmodium falciparum Kelch 13 mutations and treatment response in patients in Hpa-Pun District, Northern Kayin State, MyanmarCraig A Bonnington, Aung Pyae Phyo, Elizabeth A Ashley, et al.
The Lancet. Infectious Diseases|October 9, 2015
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trialAung Pyae Phyo, Podjanee Jittamala, François H Nosten, et al.
The Journal of Infectious Diseases|February 4, 2011
Methotrexate is highly potent against pyrimethamine-resistant Plasmodium vivaxMallika Imwong, Bruce Russell, Rossarin Suwanarusk, et al.
Malaria Journal|May 5, 2026
Methylene blue retains in vitro activity against early ring-stage artemisinin-resistant Plasmodium falciparumOlivia Verdier, Peter Christensen, Chalita Kaewkanya, et al.
Emerging Infectious Diseases|July 20, 2016
Artemisinin-Resistant Plasmodium falciparum K13 Mutant Alleles, Thailand-Myanmar BorderMikael Boullé, Benoit Witkowski, Valentine Duru, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2011
Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trialAung Pyae Phyo, Khin Maung Lwin, Ric N Price, et al.
Tropical Medicine & International Health : TM & IH|May 13, 2015
The role of point-of-care tests in antibiotic stewardship for urinary tract infections in a resource-limited setting on the Thailand-Myanmar borderLauren Chalmers, Jessica Cross, Cindy S Chu, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2012
Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malariaKhin Maung Lwin, Aung Pyae Phyo, Joel Tarning, et al.
The AAPS Journal|September 13, 2017
Population Pharmacokinetic and Pharmacodynamic Modeling of Artemisinin Resistance in Southeast AsiaJesmin Lohy Das, Arjen M Dondorp, Francois Nosten, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|January 19, 2012
Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malariaJoel Tarning, Marcus J Rijken, Rose McGready, et al.
Malaria Journal|November 28, 2017
Plasmodium falciparum Kelch 13 mutations and treatment response in patients in Hpa-Pun District, Northern Kayin State, MyanmarCraig A Bonnington, Aung Pyae Phyo, Elizabeth A Ashley, et al.
The Lancet. Infectious Diseases|October 9, 2015
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trialAung Pyae Phyo, Podjanee Jittamala, François H Nosten, et al.
The Journal of Infectious Diseases|February 4, 2011
Methotrexate is highly potent against pyrimethamine-resistant Plasmodium vivaxMallika Imwong, Bruce Russell, Rossarin Suwanarusk, et al.
Malaria Journal|May 5, 2026
Methylene blue retains in vitro activity against early ring-stage artemisinin-resistant Plasmodium falciparumOlivia Verdier, Peter Christensen, Chalita Kaewkanya, et al.
Emerging Infectious Diseases|July 20, 2016
Artemisinin-Resistant Plasmodium falciparum K13 Mutant Alleles, Thailand-Myanmar BorderMikael Boullé, Benoit Witkowski, Valentine Duru, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2011
Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trialAung Pyae Phyo, Khin Maung Lwin, Ric N Price, et al.
Tropical Medicine & International Health : TM & IH|May 13, 2015
The role of point-of-care tests in antibiotic stewardship for urinary tract infections in a resource-limited setting on the Thailand-Myanmar borderLauren Chalmers, Jessica Cross, Cindy S Chu, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2012
Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malariaKhin Maung Lwin, Aung Pyae Phyo, Joel Tarning, et al.
The AAPS Journal|September 13, 2017
Population Pharmacokinetic and Pharmacodynamic Modeling of Artemisinin Resistance in Southeast AsiaJesmin Lohy Das, Arjen M Dondorp, Francois Nosten, et al.
Pageof 10